Aberdeen Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.6M | Sell |
|
|||||
|
2025
Q2 | $14.9M | Sell |
|
|||||
|
2025
Q1 | $24.4M | Buy |
|
|||||
|
2024
Q4 | $21.4M | Buy |
|
|||||
|
2024
Q3 | $15.7M | Sell |
|
|||||
|
2024
Q2 | $22.2M | Buy |
|
|||||
|
2024
Q1 | $11.5M | Sell |
|
|||||
|
2023
Q4 | $11M | Buy |
|
|||||
|
2023
Q3 | $361K | Sell |
|
|||||
|
2023
Q2 | $328K | Buy |
|
|||||
|
2023
Q1 | $200K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $333K | Buy |
|
|||||
|
2020
Q4 | $303K | Buy |
|
|||||
|
2020
Q3 | $271K | Sell |
|
|||||
|
2020
Q2 | $622K | Sell |
|
|||||
|
2020
Q1 | $7.06M | Sell |
|
|||||
|
2019
Q4 | $8.84M | Buy |
|
|||||
|
2019
Q3 | $7.27M | Sell |
|
|||||
|
2019
Q2 | $8.47M | Sell |
|
|||||
|
2019
Q1 | $9.25M | Sell |
|
|||||
|
2018
Q4 | $7.82M | Sell |
|
|||||
|
2018
Q3 | $16.8M | Buy |
|